Cvs Health (CVS) Price to Earnings (2009 - 2026)

Cvs Health (CVS) has reported Price to Earnings for 18 consecutive years, with 44.14 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Earnings fell 48.83% year-over-year to 44.14; the trailing twelve-month figure through Jun 2026 stood at 27.06 (up 39.01% YoY), and the FY2025 full-year result was 58.37, up 373.28% from the prior year.
• Price to Earnings climbed to 44.14 in Q2 2026 per CVS's latest filing, from 30.92 in the prior quarter.
• Across five years, Price to Earnings topped out at 1114.13 in Q3 2024 and bottomed at 36.9 in Q3 2022.
• Historically, Price to Earnings has averaged 99.49 across 5 years, with a median of 44.26 in 2023.
• The sharpest annual moves came in 2022 and 2024: Price to Earnings plunged 152.23% in 2022, then jumped 2708.31% in 2024.
• Over 5 years, Price to Earnings stood at 51.95 in 2022, then fell by 4.36% to 49.68 in 2023, then decreased by 29.86% to 34.85 in 2024, then fell by 0.98% to 34.51 in 2025, then increased by 27.92% to 44.14 in 2026.
• According to Business Quant data, Price to Earnings over the past three periods registered 44.14, 30.92, and 34.51 for Q2 2026, Q1 2026, and Q4 2025 respectively.